Related references
Note: Only part of the references are listed.Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients
Seok Jin Kim et al.
ANNALS OF HEMATOLOGY (2015)
CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
Zhenyu Zhu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
Seok Jin Kim et al.
ANNALS OF HEMATOLOGY (2014)
CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
Subir Biswas et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type
Ya-Jun Li et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma
Mark P. Purdue et al.
BLOOD (2013)
Chemokines in tumor progression and metastasis
Purvaba J. Sarvaiya et al.
ONCOTARGET (2013)
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymphoma Project
Zdravko Mitrovic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong et al.
BLOOD (2012)
CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation
C. P. El-Haibi et al.
CELL PROLIFERATION (2011)
Chemokines in health and disease
Dayanidhi Raman et al.
EXPERIMENTAL CELL RESEARCH (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au et al.
BLOOD (2009)
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Seok Jin Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
Hyo Song Kim et al.
LEUKEMIA & LYMPHOMA (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation
Y. K. Jeon et al.
JOURNAL OF PATHOLOGY (2007)
Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL) - A new diagnostic marker providing evidence that AITL derives from follicular helper T cells
J Dupuis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study
J Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues
LA Ebert et al.
MOLECULAR IMMUNOLOGY (2005)
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
CS Chim et al.
BLOOD (2004)
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2003)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
